BioSpace News Archive

Imara Inc. announced that the company will deliver an oral presentation on IMR-687 at the 24th Congress of the European Hematology Association being held from June 13 – 16, 2019, in Amsterdam.

Sesen Bio announced that Dr. Thomas Cannell, President and CEO will host a conference call on Monday, June 10, 2019 at 8:00 a.m. ET to provide an update on the Company’s meeting with the FDA on June 6, 2019.

Results, presented at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting, demonstrated clinically meaningful response in patients with urothelial carcinoma whose treatment previously failed, a population with high unmet medical need

Taiho Oncology, Inc. announces that it has assumed commercialization responsibility from Otsuka Pharmaceuticals Co., Ltd., (Otsuka) for the novel fixed-dose combination of cedazuridine and decitabine (ASTX727) and guadecitabine (SGI-110) in the U.S. and Canada, subject to regulatory approvals.

Drawbridge Health today announced the upcoming presentation of results at the American Diabetes Association 79th Annual Scientific Session (#ADA2019) from a clinical study completed at the end of 2018.

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH / TSX:AUP) (the “Company”) today sent a letter to shareholders in connection with the Company’s upcoming Annual General Meeting of Shareholders (“AGM”) to be held on Wednesday, June 26, 2019.

La Fondation Dassault Systèmes, a foundation dedicated to transforming the future of education and research with the learning and discovery capabilities of 3D technology and virtual universes, today announced the development of the Ocean Explorers project to support the preservation of the world’s oceans, which play a major role in climate change.

Recognizing the importance of ensuring people with disabilities have access to the care and services they need to live better, healthier lives, WellCare Health Plans, Inc. and its Staywell Health Plan have donated $15,000 to sponsor the 21st Annual Family Café in Orlando, Florida June 7-9.

Medisanté, the world’s leading provider of medical IoT, enters the U.S. market. Peter Heiniger, CEO & Chairman of the Swiss start-up stated, “Medisanté USA, Inc. opened its new headquarters in Bridgewater, New Jersey, and we are happy to name Tony Sulsona, an established commercialization executive from the U.S. medical device industry, as Managing Director of our U.S. business.

Best Friend Fridays fetch funds for heart research and the American Heart Association